Title: 2025-2026 Regular Session HB 916 PN 0965 Bill Text (HTM)
Official Title: 
Number of Sections: 1
Source: versions - Printer's No. PN0965
Media Type: text/html

================================================================================

Section 1:
2025-2026 Regular Session HB 916 PN 0965 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 965 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE BILL No.916 Session of 2025 INTRODUCED BY GIRAL, PIELLI, SANCHEZ, McNEILL, HILL-EVANS, SCHLOSSBERG, HOHENSTEIN, CIRESI, OTTEN, WEBSTER AND GREEN, MARCH 17, 2025 REFERRED TO COMMITTEE ON HEALTH, MARCH 17, 2025 AN ACTAmending the act of November 3, 2022 (P.L.2135, No.150), entitled "An act providing for blood lead assessment and testing of certain children and pregnant women by health care providers; imposing duties on the Department of Health; and requiring certain health insurance policies to cover blood lead tests," further providing for legislative findings and for definitions; repealing provisions relating to lead poisoning prevention, assessment and testing; providing for lead poisoning prevention, assessment and testing; and further providing for duties of department and for blood lead assessment and testing coverage.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. Section 2 of the act of November 3, 2022 (P.L.2135, No.150), known as the Childhood Blood Lead Test Act, is amended by adding paragraphs to read:Section 2. Legislative findings.The General Assembly finds that:* * *(8) No safe blood lead level in children has been identified.(9) The effects of lead poisoning are not reversible.12345678910111213141516171819202122 Section 2. Section 4 of the act is amended by adding definitions to read:Section 4. Definitions.The following words and phrases when used in this act shall have the meanings given to them in this section unless the context clearly indicates otherwise:"Birthing facility." An inpatient or ambulatory health care facility licensed by the department that provides birthing and newborn care services."Blood lead level." A measure of lead in the blood, measured in micrograms of lead per deciliter of whole blood (µg/dL).* * *"Child." A child younger than 72 months of age who is a resident of this Commonwealth.* * *"Diagnostic blood lead level testing." An analysis of a blood sample to determine blood lead levels for the sample, which is obtained by venipuncture or capillary blood sampling for the purpose of any of the following:(1) Confirming lead poisoning as a follow-up blood lead level test.(2) Diagnosing a child or pregnant woman showing signs or symptoms of lead poisoning.(3) Diagnosing a child or pregnant woman suspected of having sustained a significant lead exposure."Diagnostic evaluation." Obtaining and evaluating medical history information, conducting a physical examination and diagnostic blood lead level testing, identifying potential sources of lead exposure and evaluating iron status.* * *20250HB0916PN0965 - 2 - 123456789101112131415161718192021222324252627282930 "Lead poisoning." A blood lead level that meets one of the following criteria:(1) A confirmed blood lead level greater than or equal to 20 µg/dL in a child or pregnant woman.(2) Two blood lead level samples of a child or pregnant woman, separated by at least 90 days, but not more than 365 days, which indicate a blood lead level greater than or equal to 15 µg/dL."Lead-screening-related services." Any of the following:(1) Materials and supplies used to obtain blood specimens for quantitative blood lead level or erythrocyte protoporphyrin analysis.(2) Laboratory analysis of submitted samples for quantitative blood lead level testing or erythrocyte protoporphyrin analysis.(3) Evaluation of results obtained from laboratory analysis of samples submitted for quantitative blood lead level or erythrocyte protoporphyrin analysis, as well as related consultation, referral and follow-up of children and pregnant women who potentially have lead poisoning."Screening test." A blood sample obtained by venipuncture or capillary blood sampling from an asymptomatic child or pregnant woman not known to have lead poisoning to identify risk of lead poisoning for the child or pregnant woman.Section 3. Section 5 of the act is repealed:[Section 5. Lead poisoning prevention, assessment and testing.(a) Lead testing for children.--(1) The following apply:(i) A health care provider shall consider possible lead exposure in an individual patient by evaluating risk 20250HB0916PN0965 - 3 - 123456789101112131415161718192021222324252627282930 factors for lead exposure and perform blood lead testing in accordance with recommendations from the Centers for Disease Control and Prevention and the American Academy of Pediatrics by 24 months of age.(ii) If a patient has never been tested in accordance with recommendations from the Centers for Disease Control and Prevention and the American Academy of Pediatrics by 24 months of age, a health care provider shall consider possible lead exposure and perform blood lead testing in an individual patient between 24 months and 72 months of age.(iii) A health care provider shall make reasonable efforts to ensure that a patient's parent or legal guardian understands the risks and benefits of blood lead testing prior to obtaining consent.(2) If a patient's parent or legal guardian consents to blood lead testing for the patient under paragraph (1) and the results of a capillary blood lead test indicate an elevated blood lead level, the health care provider shall perform a confirmatory blood lead test by venipuncture within 12 weeks of the first blood lead test after obtaining the consent of the patient's parent or legal guardian.(b) Lead exposure risk assessment and testing requirements for pregnant women.--A health care provider shall consider possible lead exposure in individual pregnant women by evaluating risk factors for lead exposure and perform blood lead testing if a single risk factor is identified in accordance with recommendations from the Centers for Disease Control and Prevention and the American College of Obstetricians and Gynecologists.20250HB0916PN0965 - 4 - 123456789101112131415161718192021222324252627282930 (c) Reporting.--Health care providers and laboratories shall comply with reporting regulations as specified in 28 Pa. Code § 27.34 (relating to reporting cases of lead poisoning).]Section 4. The act is amended by adding a section to read:Section 5.1. Lead poisoning prevention, assessment and testing.(a) Lead testing requirements for children.--(1) A health care provider or certified assistant of a health care provider shall make reasonable efforts to ensure that a child under the health care provider's care receives at least one blood lead test by 24 months of age or between the ages of 24 through 72 months of age if the child has never been tested in accordance with recommendations from the Centers for Disease Control and Prevention and the American Academy of Pediatrics.(2) If the results of a blood lead test under paragraph (1) indicate an elevated blood lead level, the health care provider or certified assistant of the health care provider shall perform a confirmatory blood lead test on the child within 12 weeks of the first blood lead test.(3) A health care provider or certified assistant of a health care provider shall perform a screening test for a child under the health care provider's care who is designated as high risk through a risk assessment evaluation promulgated by the department on an annual basis from 12 months of age to 72 months of age.(4) Upon recommendation by a health care provider, a health care provider or certified assistant of a health care provider may perform frequent screening tests on an asymptomatic child under the health care provider's care who is younger than 72 months of age.20250HB0916PN0965 - 5 - 123456789101112131415161718192021222324252627282930 (b) Lead testing requirements for pregnant women.--A health care provider or certified assistant of a health care provider shall make reasonable efforts to ensure that a pregnant woman under the health care provider's care receives at least one blood lead test as part of the pregnant woman's prenatal care.(c) Testing methods.--Health care providers shall ensure that screening tests are conducted by venipuncture or capillary blood sampling in accordance with regulations promulgated by the department.(d) Reporting.--Health care providers and laboratories shall comply with reporting regulations as specified in 28 Pa. Code § 27.34 (relating to reporting cases of lead poisoning).(e) Nonapplicability.--If a child's parent or legal guardian or a pregnant woman receiving prenatal care objects in writing to a blood lead test on religious grounds or on the basis of a strong moral or ethical conviction similar to a religious belief, a health care provider or certified assistant of the health care provider shall perform a diagnostic evaluation in the least invasive manner practicable.Section 5. Section 6(b)(1) of the act is amended, the subsection is amended by adding paragraphs and the section is amended by adding a subsection to read:Section 6. Duties of department.* * *(b) Distribution of literature about childhood lead poisoning.--(1) The department shall provide culturally and linguistically appropriate educational materials regarding childhood lead poisoning, the risk factors associated with lead exposure, the importance of assessments and testing for 20250HB0916PN0965 - 6 - 123456789101112131415161718192021222324252627282930 elevated lead levels, prevention of childhood lead poisoning, treatment of childhood lead poisoning, remediation and, when appropriate, the requirements of this act.* * *(3) A hospital, birthing facility or health care provider shall provide the information under subsection (a) and the educational materials under this subsection without cost to a parent of a newborn prior to discharge from the hospital or birthing facility or, if childbirth occurs in a setting other than a hospital or birthing facility, by a health care provider who assists the parent during childbirth.(4) A parent of a newborn prior to discharge from a hospital or birthing facility, or after a childbirth that takes place in a setting other than a hospital or birthing facility, shall sign an acknowledgment statement in a form determined by the department that the parent received the information under subsection (a) and the educational materials under this subsection. A hospital, birthing facility or health care provider shall provide a copy of the acknowledgment statement to the parent and keep another copy of the acknowledgment statement on file at the hospital, birthing facility or setting other than a hospital or birthing facility, as applicable.(c) Liability.--A hospital, birthing facility or health care provider shall not be civilly or criminally liable for the action or inaction of a parent with regard to lead exposure based on the information under subsection (a) and the educational materials under subsection (b).Section 6. Section 7(a) of the act is amended and the 20250HB0916PN0965 - 7 - 123456789101112131415161718192021222324252627282930 section is amended by adding subsections to read:Section 7. Blood lead assessment and testing coverage.(a) [General rule] Coverage.--A health insurance policy or government program covered under this section shall provide to covered individuals or recipients [blood lead tests as follows:(1) In the case of individuals or recipients who are pregnant, one blood lead test per pregnancy if a single risk factor is identified in accordance with recommendations from the Centers for Disease Control and Prevention and the American College of Obstetricians and Gynecologists.(2) In the case of individuals or recipients who are under two years of age, at least one blood lead test by 24 months of age in accordance with recommendations from the Centers for Disease Control and Prevention and the American Academy of Pediatrics and, if the result of the blood level test indicates an elevated blood lead level, another blood lead test by venipuncture within 12 weeks of the blood level test in which the elevated blood lead level was indicated.] coverage for all of the following:(3) Screening tests and lead-screening-related services for children younger than 72 months of age and pregnant women.(4) Diagnostic evaluations. (a.1) Services.--The department shall provide the following services for children younger than 72 months of age and pregnant women who are not covered by a health insurance policy:(1) Screening tests and lead-screening-related services.(2) Diagnostic evaluations.(a.2) Reimbursement.--The department shall not be required to reimburse a third party for services under subsection (b) 20250HB0916PN0965 - 8 - 123456789101112131415161718192021222324252627282930 that are not provided by the department.* * *Section 7. This act shall take effect in 60 days.20250HB0916PN0965 - 9 - 123


================================================================================

Raw Text:
2025-2026 Regular Session HB 916 PN 0965 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 965 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE BILL No.916 Session of 2025 INTRODUCED BY GIRAL, PIELLI, SANCHEZ, McNEILL, HILL-EVANS, SCHLOSSBERG, HOHENSTEIN, CIRESI, OTTEN, WEBSTER AND GREEN, MARCH 17, 2025 REFERRED TO COMMITTEE ON HEALTH, MARCH 17, 2025 AN ACTAmending the act of November 3, 2022 (P.L.2135, No.150), entitled "An act providing for blood lead assessment and testing of certain children and pregnant women by health care providers; imposing duties on the Department of Health; and requiring certain health insurance policies to cover blood lead tests," further providing for legislative findings and for definitions; repealing provisions relating to lead poisoning prevention, assessment and testing; providing for lead poisoning prevention, assessment and testing; and further providing for duties of department and for blood lead assessment and testing coverage.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. Section 2 of the act of November 3, 2022 (P.L.2135, No.150), known as the Childhood Blood Lead Test Act, is amended by adding paragraphs to read:Section 2. Legislative findings.The General Assembly finds that:* * *(8) No safe blood lead level in children has been identified.(9) The effects of lead poisoning are not reversible.12345678910111213141516171819202122 Section 2. Section 4 of the act is amended by adding definitions to read:Section 4. Definitions.The following words and phrases when used in this act shall have the meanings given to them in this section unless the context clearly indicates otherwise:"Birthing facility." An inpatient or ambulatory health care facility licensed by the department that provides birthing and newborn care services."Blood lead level." A measure of lead in the blood, measured in micrograms of lead per deciliter of whole blood (µg/dL).* * *"Child." A child younger than 72 months of age who is a resident of this Commonwealth.* * *"Diagnostic blood lead level testing." An analysis of a blood sample to determine blood lead levels for the sample, which is obtained by venipuncture or capillary blood sampling for the purpose of any of the following:(1) Confirming lead poisoning as a follow-up blood lead level test.(2) Diagnosing a child or pregnant woman showing signs or symptoms of lead poisoning.(3) Diagnosing a child or pregnant woman suspected of having sustained a significant lead exposure."Diagnostic evaluation." Obtaining and evaluating medical history information, conducting a physical examination and diagnostic blood lead level testing, identifying potential sources of lead exposure and evaluating iron status.* * *20250HB0916PN0965 - 2 - 123456789101112131415161718192021222324252627282930 "Lead poisoning." A blood lead level that meets one of the following criteria:(1) A confirmed blood lead level greater than or equal to 20 µg/dL in a child or pregnant woman.(2) Two blood lead level samples of a child or pregnant woman, separated by at least 90 days, but not more than 365 days, which indicate a blood lead level greater than or equal to 15 µg/dL."Lead-screening-related services." Any of the following:(1) Materials and supplies used to obtain blood specimens for quantitative blood lead level or erythrocyte protoporphyrin analysis.(2) Laboratory analysis of submitted samples for quantitative blood lead level testing or erythrocyte protoporphyrin analysis.(3) Evaluation of results obtained from laboratory analysis of samples submitted for quantitative blood lead level or erythrocyte protoporphyrin analysis, as well as related consultation, referral and follow-up of children and pregnant women who potentially have lead poisoning."Screening test." A blood sample obtained by venipuncture or capillary blood sampling from an asymptomatic child or pregnant woman not known to have lead poisoning to identify risk of lead poisoning for the child or pregnant woman.Section 3. Section 5 of the act is repealed:[Section 5. Lead poisoning prevention, assessment and testing.(a) Lead testing for children.--(1) The following apply:(i) A health care provider shall consider possible lead exposure in an individual patient by evaluating risk 20250HB0916PN0965 - 3 - 123456789101112131415161718192021222324252627282930 factors for lead exposure and perform blood lead testing in accordance with recommendations from the Centers for Disease Control and Prevention and the American Academy of Pediatrics by 24 months of age.(ii) If a patient has never been tested in accordance with recommendations from the Centers for Disease Control and Prevention and the American Academy of Pediatrics by 24 months of age, a health care provider shall consider possible lead exposure and perform blood lead testing in an individual patient between 24 months and 72 months of age.(iii) A health care provider shall make reasonable efforts to ensure that a patient's parent or legal guardian understands the risks and benefits of blood lead testing prior to obtaining consent.(2) If a patient's parent or legal guardian consents to blood lead testing for the patient under paragraph (1) and the results of a capillary blood lead test indicate an elevated blood lead level, the health care provider shall perform a confirmatory blood lead test by venipuncture within 12 weeks of the first blood lead test after obtaining the consent of the patient's parent or legal guardian.(b) Lead exposure risk assessment and testing requirements for pregnant women.--A health care provider shall consider possible lead exposure in individual pregnant women by evaluating risk factors for lead exposure and perform blood lead testing if a single risk factor is identified in accordance with recommendations from the Centers for Disease Control and Prevention and the American College of Obstetricians and Gynecologists.20250HB0916PN0965 - 4 - 123456789101112131415161718192021222324252627282930 (c) Reporting.--Health care providers and laboratories shall comply with reporting regulations as specified in 28 Pa. Code § 27.34 (relating to reporting cases of lead poisoning).]Section 4. The act is amended by adding a section to read:Section 5.1. Lead poisoning prevention, assessment and testing.(a) Lead testing requirements for children.--(1) A health care provider or certified assistant of a health care provider shall make reasonable efforts to ensure that a child under the health care provider's care receives at least one blood lead test by 24 months of age or between the ages of 24 through 72 months of age if the child has never been tested in accordance with recommendations from the Centers for Disease Control and Prevention and the American Academy of Pediatrics.(2) If the results of a blood lead test under paragraph (1) indicate an elevated blood lead level, the health care provider or certified assistant of the health care provider shall perform a confirmatory blood lead test on the child within 12 weeks of the first blood lead test.(3) A health care provider or certified assistant of a health care provider shall perform a screening test for a child under the health care provider's care who is designated as high risk through a risk assessment evaluation promulgated by the department on an annual basis from 12 months of age to 72 months of age.(4) Upon recommendation by a health care provider, a health care provider or certified assistant of a health care provider may perform frequent screening tests on an asymptomatic child under the health care provider's care who is younger than 72 months of age.20250HB0916PN0965 - 5 - 123456789101112131415161718192021222324252627282930 (b) Lead testing requirements for pregnant women.--A health care provider or certified assistant of a health care provider shall make reasonable efforts to ensure that a pregnant woman under the health care provider's care receives at least one blood lead test as part of the pregnant woman's prenatal care.(c) Testing methods.--Health care providers shall ensure that screening tests are conducted by venipuncture or capillary blood sampling in accordance with regulations promulgated by the department.(d) Reporting.--Health care providers and laboratories shall comply with reporting regulations as specified in 28 Pa. Code § 27.34 (relating to reporting cases of lead poisoning).(e) Nonapplicability.--If a child's parent or legal guardian or a pregnant woman receiving prenatal care objects in writing to a blood lead test on religious grounds or on the basis of a strong moral or ethical conviction similar to a religious belief, a health care provider or certified assistant of the health care provider shall perform a diagnostic evaluation in the least invasive manner practicable.Section 5. Section 6(b)(1) of the act is amended, the subsection is amended by adding paragraphs and the section is amended by adding a subsection to read:Section 6. Duties of department.* * *(b) Distribution of literature about childhood lead poisoning.--(1) The department shall provide culturally and linguistically appropriate educational materials regarding childhood lead poisoning, the risk factors associated with lead exposure, the importance of assessments and testing for 20250HB0916PN0965 - 6 - 123456789101112131415161718192021222324252627282930 elevated lead levels, prevention of childhood lead poisoning, treatment of childhood lead poisoning, remediation and, when appropriate, the requirements of this act.* * *(3) A hospital, birthing facility or health care provider shall provide the information under subsection (a) and the educational materials under this subsection without cost to a parent of a newborn prior to discharge from the hospital or birthing facility or, if childbirth occurs in a setting other than a hospital or birthing facility, by a health care provider who assists the parent during childbirth.(4) A parent of a newborn prior to discharge from a hospital or birthing facility, or after a childbirth that takes place in a setting other than a hospital or birthing facility, shall sign an acknowledgment statement in a form determined by the department that the parent received the information under subsection (a) and the educational materials under this subsection. A hospital, birthing facility or health care provider shall provide a copy of the acknowledgment statement to the parent and keep another copy of the acknowledgment statement on file at the hospital, birthing facility or setting other than a hospital or birthing facility, as applicable.(c) Liability.--A hospital, birthing facility or health care provider shall not be civilly or criminally liable for the action or inaction of a parent with regard to lead exposure based on the information under subsection (a) and the educational materials under subsection (b).Section 6. Section 7(a) of the act is amended and the 20250HB0916PN0965 - 7 - 123456789101112131415161718192021222324252627282930 section is amended by adding subsections to read:Section 7. Blood lead assessment and testing coverage.(a) [General rule] Coverage.--A health insurance policy or government program covered under this section shall provide to covered individuals or recipients [blood lead tests as follows:(1) In the case of individuals or recipients who are pregnant, one blood lead test per pregnancy if a single risk factor is identified in accordance with recommendations from the Centers for Disease Control and Prevention and the American College of Obstetricians and Gynecologists.(2) In the case of individuals or recipients who are under two years of age, at least one blood lead test by 24 months of age in accordance with recommendations from the Centers for Disease Control and Prevention and the American Academy of Pediatrics and, if the result of the blood level test indicates an elevated blood lead level, another blood lead test by venipuncture within 12 weeks of the blood level test in which the elevated blood lead level was indicated.] coverage for all of the following:(3) Screening tests and lead-screening-related services for children younger than 72 months of age and pregnant women.(4) Diagnostic evaluations. (a.1) Services.--The department shall provide the following services for children younger than 72 months of age and pregnant women who are not covered by a health insurance policy:(1) Screening tests and lead-screening-related services.(2) Diagnostic evaluations.(a.2) Reimbursement.--The department shall not be required to reimburse a third party for services under subsection (b) 20250HB0916PN0965 - 8 - 123456789101112131415161718192021222324252627282930 that are not provided by the department.* * *Section 7. This act shall take effect in 60 days.20250HB0916PN0965 - 9 - 123